Return to Home [X]

Exciting News: Introducing the New Essential Evidence Plus!

We are thrilled to announce that a brand-new version of Essential Evidence Plus is on its way! Mark your calendars for the launch date, September 11th, as we are introducing a modern, mobile-first application that will revolutionize your experience. With this update, accessing our valuable content will be easier and more convenient than ever before.

What to Expect from the New Essential Evidence Plus:

  1. Modern Mobile-First Experience: Our new application has been meticulously designed with a mobile-first approach. No matter what device you're using, whether it's a smartphone, tablet, or desktop, you'll enjoy a seamless and intuitive user experience.
  2. Enhanced Accessibility: We understand the importance of accessing content from anywhere, at any time. The new Essential Evidence Plus will provide you with the flexibility to explore our extensive collection of evidence-based resources on the go, making it easier to stay up to date with the latest medical knowledge and interactive tools.
  3. Improved User Interface: We have revamped our user interface to ensure effortless navigation and a visually appealing experience. Finding the information, you need will be quicker and more intuitive, saving you valuable time and effort.

Essential Evidence Plus will be available to users during this transition. However, please note that ability to create new trial and individual subscriptions will not be available from September 8th to September 11th 7:00 AM EST. During this period, we will be working diligently to transfer our existing system to the upgraded platform, ensuring a seamless transition for all users.

We apologize for any inconvenience caused by this temporary interruption. Rest assured, our team is committed to bringing you a superior user experience, and we appreciate your patience and understanding during this time.

Stay Tuned for the New Essential Evidence Plus!

We are counting down the days until September 11th when the new Essential Evidence Plus will be available for you to explore. Get ready to unlock a wealth of evidence-based resources that empower you in your medical decision-making process.

Thank you for your continued support, and we look forward to delivering an exceptional experience with the all-new Essential Evidence Plus!

Essential Evidence Plus

Browse Databases and Tools

Sort by Show per page
  • Seclusion and restraint for people with serious mental illnesses
    Cochrane Systematic Reviews, 24-Jan-2000
  • Second‐generation antidepressants for treatment of seasonal affective disorder
    Cochrane Systematic Reviews, 4-Mar-2021
  • Second-generation antipsychotics for anxiety disorders
    Cochrane Systematic Reviews, 26-Oct-2011
  • Second-generation antipsychotics for major depressive disorder and dysthymia
    Cochrane Systematic Reviews, 18-Jan-2012
  • Second-generation antipsychotics for obsessive compulsive disorder
    Cochrane Systematic Reviews, 10-Nov-2010
  • Sedatives for opioid withdrawal in newborn infants
    Cochrane Systematic Reviews, 18-May-2021
  • Selective serotonin reuptake inhibitors (SSRIs) and serotonin‐norepinephrine reuptake inhibitors (SNRIs) for the prevention of migraine in adults
    Cochrane Systematic Reviews, 1-Apr-2015
  • Selective serotonin reuptake inhibitors (SSRIs) for autism spectrum disorders (ASD)
    Cochrane Systematic Reviews, 8-Aug-2013
  • Selective serotonin reuptake inhibitors (SSRIs) versus other antidepressants for depression
    Cochrane Systematic Reviews, 31-Oct-2008
  • Selective serotonin re‐uptake inhibitors (SSRIs) versus placebo for obsessive compulsive disorder (OCD)
    Cochrane Systematic Reviews, 23-Jan-2008
  • Selective serotonin reuptake inhibitors for premenstrual syndrome
    Cochrane Systematic Reviews, 7-Jun-2013
  • Selegiline for Alzheimer's disease
    Cochrane Systematic Reviews, 12-May-2008
  • Self-help and guided self-help for eating disorders
    Cochrane Systematic Reviews, 5-Nov-2008
  • Sensory environment on health-related outcomes of hospital patients
    Cochrane Systematic Reviews, 15-Feb-2012
  • Sertindole for schizophrenia
    Cochrane Systematic Reviews, 20-Jul-2005
  • Sertindole versus other atypical antipsychotics for schizophrenia
    Cochrane Systematic Reviews, 15-Apr-2009
  • Sertraline versus other antidepressive agents for depression
    Cochrane Systematic Reviews, 14-Apr-2010
  • Shared decision‐making interventions for people with mental health conditions
    Cochrane Systematic Reviews, 11-Nov-2022
  • Short‐term psychodynamic psychotherapies for common mental disorders
    Cochrane Systematic Reviews, 1-Jul-2014
  • Silver acetate for smoking cessation
    Cochrane Systematic Reviews, 12-Sep-2012

Login or Subscribe


Not Yet a Subscriber?

Doctor with handheld

We offer subscriptions for individuals and institutions

To find out about all the benefits of a year-long subscription to Essential Evidence Plus, click the button below!

Learn More